Review
Cardiac & Cardiovascular Systems
Yan Zhou, Xueping Zhu, Hanming Cui, Jingjing Shi, Guozhen Yuan, Shuai Shi, Yuanhui Hu
Summary: The VEGF family, known for its role in regulating blood and lymphatic vessels, shows promise for treating coronary heart disease (CHD) by regulating various functions such as angiogenesis, apoptosis, inflammation, and fibrogenesis. Through binding with different receptors, VEGF proteins can modulate distinct physiological processes, offering potential pathways for treating CHD.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Endocrinology & Metabolism
Xin Wang, Ya-li Wu, Yuan-yuan Zhang, Jing Ke, Zong-wei Wang, Bao-yu Zhang, Yan Ma, Long-yan Yang, Dong Zhao
Summary: AK098656 expression is significantly increased in patients with CHD, especially those with hypertension. The expression level of AK098656 is positively correlated with the degree of coronary stenosis. This suggests that AK098656 may be a risk factor for CHD and can potentially serve as a novel target for clinical diagnosis or treatment.
DIABETOLOGY & METABOLIC SYNDROME
(2022)
Article
Medical Laboratory Technology
Yan Jiang, Tian Du
Summary: This study found that circulating lnc-GAS5 and miR-21 levels were associated with biochemical indexes, stenosis severity, and inflammatory cytokines in patients with coronary heart disease (CHD). They may serve as potential biomarkers for the management of CHD.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2022)
Article
Medical Laboratory Technology
Wenwu Liu, Shuwei Weng, Huixing Liu, Chenghui Cao, Shuai Wang, Sha Wu, Jia He, Yang Yang, Die Hu, Yonghong Luo, Daoquan Peng
Summary: This study found that serum soluble TREM2 levels are elevated in patients with coronary heart disease (CHD) and are associated with various cardiovascular risk factors. Compared to traditional indicators, sTREM2 has better diagnostic performance in identifying CHD, suggesting that sTREM2 may serve as a potential biomarker for coronary heart disease.
CLINICA CHIMICA ACTA
(2023)
Article
Medical Laboratory Technology
Xiaoyun Zhang, Xuetong Kan, Jingjing Shen, Jian Li
Summary: This study found that increased expression of lnc-NORAD is associated with aggravated stenosis degree, inflammation status, and abnormal blood lipid levels in patients with coronary heart disease.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2022)
Review
Pharmacology & Pharmacy
Miao-Miao Tang, Shu-Ting Zhao, Ran-Qi Li, Wei Hou
Summary: Coronary heart disease (CHD) is a common clinical manifestation of cardiovascular disease, characterized by myocardial ischemia caused by coronary atherosclerosis. Ginseng has been found to improve cardiac function by regulating blood glucose levels, reducing blood pressure, oxidative stress, platelet aggregation, and lipid dysregulation. It can be considered as an alternative therapy for CHD.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Genetics & Heredity
Liangping Zhao, Li Wang, Daimin Zhang, Yuqi Chen, Fulu Jin
Summary: The research showed that puerarin could alleviate coronary heart disease in rats by suppressing inflammation, improving cardiac function, and regulating the expression of key proteins and factors, including those affecting cholesterol and lipid levels.
Article
Chemistry, Analytical
Hao-Wen Li, Zhan Hu, Xiao Chen, Jie Ren, Hao Cui, Min Zhang, Liang Chen, Xin Hua, Jiangping Song, Yi-Tao Long
Summary: The study analyzed alterations in lipid metabolites in coronary artery tissues throughout the progression of atherosclerosis using ToF-SIMS mass spectrometry. Detailed descriptions of lipid features were obtained, a database of AS lipids was constructed, and the linoleic acid and arachidonic acid metabolic pathways were predicted to play critical roles in AS progression.
ANALYTICAL CHEMISTRY
(2021)
Article
Oncology
Sanne G. M. van Velzen, Steffen Bruns, Jelmer M. Wolterink, Tim Leiner, Max A. Viergever, Helena M. Verkooijen, Ivana Isgum
Summary: This study aims to develop and evaluate an automatic deep learning method for segmentation of cardiac chambers and large arteries, and localization of the 3 main coronary arteries in radiation therapy planning on computed tomography (CT). The study found that the developed method can automatically obtain accurate estimates of planned radiation dose and dosimetric parameters for the cardiac chambers, large arteries, and coronary arteries.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(2022)
Article
Cardiac & Cardiovascular Systems
Travis Tagami, Muayad F. Almahariq, Dinu Balanescu, Thomas J. Quinn, Joshua T. Dilworth, Barry A. Franklin, Abhay Bilolikar
Summary: The risk of coronary disease is increased in breast cancer patients after radiotherapy, with left breast cancer patients having a higher risk compared to right breast cancer patients. The incidence of coronary disease is strongly correlated with radiation doses.
AMERICAN JOURNAL OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Feng Xiong, Rui Mao, Ruohan Zhao, Lijuan Zhang, Kunyue Tan, Chunxia Liu, Shuzhen Wang, Min Xu, Yi Li, Tongtong Zhang
Summary: This study identified potential non-invasive biomarkers for coronary heart disease (CHD) screening by analyzing the mRNA expression levels in small extracellular vesicles (sEVs). Upregulated S1PR5 and downregulated CARNS1 in sEVs showed significant differences between CHD patients and non-CHD patients, and were correlated with various clinical parameters. These findings suggest that S1PR5 and CARNS1 have the potential to become non-invasive biomarkers for CHD screening.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Medical Laboratory Technology
Lin Zhu, Qiang Feng, Jie Fan, Jing Huang, Yanling Zhu, Yanqiang Wu, Aijun Hou, Yanfei Huo
Summary: This study evaluated whether lncRNA KCNQ1OT1 could serve as a biomarker for reflecting the disease situation and prognosis of coronary heart disease patients. The results showed that circulating lncRNA KCNQ1OT1 expression not only reflected the stenosis degree, blood lipid level, and inflammation status but also predicted the risk of major adverse cardiac events (MACE).
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2023)
Review
Medicine, General & Internal
Pier Luigi Temporelli, Marcello Arca, Laura D'Erasmo, Raffaele De Caterina
Summary: Hyperlipidemia is a significant risk factor for coronary heart disease, but its relationship to stroke has been less clear. Recent data demonstrate the positive impact of cholesterol-lowering on stroke, while also dispelling concerns about increased risk of hemorrhagic stroke. Despite guidelines recommending aggressive lipid-lowering therapy for at-risk patients, secondary prevention patients often do not receive adequate treatment.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Borek Foldyna, Thomas Mayrhofer, Michael T. Lu, Julia Karady, Marton Kolossvary, Maros Ferencik, Svati H. Shah, Neha J. Pagidipati, Pamela S. Douglas, Udo Hoffmann
Summary: The prognostic value of CT-derived coronary artery disease (CAD) characteristics differs across categories of clinical cardiovascular risk. Among patients with low cardiovascular disease risk, CAD >= 50% has the highest prognostic value, while coronary artery calcium (CAC) and high-risk plaque (HRP) have higher prognostic value among patients with high cardiovascular disease risk.
EUROPEAN RADIOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Denise Biagini, Silvia Ghimenti, Alessio Lenzi, Andrea Bonini, Federico Vivaldi, Camille Oger, Jean-Marie Galano, Laurence Balas, Thierry Durand, Pietro Salvo, Fabio Di Francesco, Tommaso Lomonaco
Summary: Cardiovascular diseases (CVDs) are the leading cause of premature death and disability, and oxidative stress and inflammation play key roles. This study proposes a powerful MS-based platform for measuring salivary lipid mediators in CVD samples. Saliva, as a non-invasive alternative to blood, was collected from patients with heart failure, obesity, and hypertension. The results suggest that lipid mediators may serve as predictive markers for re-acutisation episodes in heart failure patients, providing opportunities for preventive intervention and reduced hospitalizations.
FREE RADICAL BIOLOGY AND MEDICINE
(2023)